Patents by Inventor Laki Buluwela

Laki Buluwela has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120077270
    Abstract: A method for suppressing the expression of a selected gene in a cell, the method comprising introducing into the cell a molecule comprising (1) a nucleic acid binding portion which binds to a site or associated with the selected gene which site is present in a genome and (2) an expression repressor portion, wherein the nucleic acid binding portion comprises an oligonucleotide or oligonucleotide mimic or analogue, and wherein the repressor portion comprises a polypeptide or peptidomimetic. Molecules for use in the methods of the invention are provided. The repressor may be a portion of a histone deacetylase or DNA methylase or polypeptide capable of recruiting a histone deacetylase or DNA methylase.
    Type: Application
    Filed: October 3, 2011
    Publication date: March 29, 2012
    Applicant: IMPERIAL COLLEGE INNOVATIONS LIMITED
    Inventors: Stephen Hart, Simak Ali, Boris Tumi PuFong, Andrew C.G. Porter, Laki Buluwela, Satu Vainikka, John David Jenkinson, Patrick Kanda
  • Publication number: 20110189669
    Abstract: The current invention provides a method for aiding in the assessment of prostate cancer (including metastatic prostate cancer) and/or benign prostate hyperplasia in a patient, wherein the method comprises the step of determining the level of Glycine N-methyltransferase (GNMT) nucleic acid and/or protein in a sample from the patient. The invention also provides compounds that target Glycine N-methyltransferase (GNMT) protein and/or nucleic acid for use in treating prostate cancer. Also provided are screening methods for selecting a compound considered to be useful in treating prostate cancer, comprising the steps of determining the ability of a test compound to reduce GNMT activity and selecting a compound that reduces GNMT activity. The invention also provides methods for aiding in the diagnosis of prostate cancer in a patient comprising obtaining a sample from the patient and assessing said sample for a marker of GNMT activity.
    Type: Application
    Filed: June 19, 2009
    Publication date: August 4, 2011
    Applicant: IMPERIAL INNOVATIONS LIMITED
    Inventors: Laki Buluwela, Jonathan Waxman, Simak Ali, Sarah Ngan
  • Publication number: 20090082250
    Abstract: A method for suppressing the expression of a selected gene in a cell the method comprising introducing into the cell a molecule comprising (1) a nucleic acid binding portion which binds to a site or associated with the selected gene which site is present in a genome and (2) an expression repressor portion, wherein the nucleic acid binding portion comprises an oligonucleotide or oligonucleotide mimic or analogue, and wherein the repressor portion comprises a polypeptide or peptidomimetic. Molecules for use in the methods of the invention are provided. The repressor may be a portion of a histone deacetylase or DNA methylase or polypeptide capable of recruiting a histone deacetylase or DNA methylase.
    Type: Application
    Filed: May 13, 2008
    Publication date: March 26, 2009
    Applicant: IMPERIAL COLLEGEINNOVATIONS LIMITED
    Inventors: Stephen Hart, Simak Ali, Boris Tumi PuFong, Andrew C. G. Porter, Laki Buluwela, Satu Vainikka, John David Jenkinson, Patrick Kanda
  • Publication number: 20050136040
    Abstract: A method for suppressing the expression of a selected gene in a cell the method comprising introducing into the cell a molecule comprising (1) a nucleic acid binding portion which binds to a site or associated with the selected gene which site is present in a genome and (2) an expression repressor portion, wherein the nucleic acid binding portion comprises an oligonucleotide or oligonucleotide mimic or analogue, and wherein the repressor portion comprises a polypeptide or peptidomimetic. Molecules for use in the methods of the invention are provided. The repressor may be a portion of a histone deacetylase or DNA methylase or polypeptide capable of recruiting a histone deacetylase or DNA methylase.
    Type: Application
    Filed: April 8, 2004
    Publication date: June 23, 2005
    Applicant: Imperial College Innovations Limited
    Inventors: Stephen Hart, Simak Ali, Boris PuFong, Andrew Porter, Laki Buluwela, Satu Vainikka, John Jenkinson, Patrick Kanda